CVS - CVS Health Corp Stock Price, Fair Value and News

55.25USD-0.49 (-0.88%)Delayed as of 08 May 2024, 01:54 pm ET

Market Summary

USD55.25-0.49

Delayedas of 08 May 2024, 01:54 pm

-0.88%

CVS Alerts

2 major insider buys recently.

Big fall in earnings (Y/Y)

CVS Stock Price

View Fullscreen

CVS RSI Chart

CVS Valuation

Market Cap

70.0B

Price/Earnings (Trailing)

9.55

Price/Sales (Trailing)

0.19

EV/EBITDA

6.85

Price/Free Cashflow

8.6

CVS Price/Sales (Trailing)

CVS Profitability

Operating Margin

56.72%

EBT Margin

2.74%

Return on Equity

9.88%

Return on Assets

2.93%

Free Cashflow Yield

11.63%

CVS Fundamentals

CVS Revenue

Revenue (TTM)

360.9B

Rev. Growth (Yr)

3.7%

Rev. Growth (Qtr)

-5.73%

CVS Earnings

Earnings (TTM)

7.3B

Earnings Growth (Yr)

-48.04%

Earnings Growth (Qtr)

-45.35%

Breaking Down CVS Revenue

52 Week Range

54.7077.38

(Low)(High)

Last 7 days

-17.7%

Last 30 days

-25.3%

Last 90 days

-26.7%

Trailing 12 Months

-20.0%

How does CVS drawdown profile look like?

CVS Financial Health

Current Ratio

0.81

Debt/Equity

0.78

Debt/Cashflow

0.19

CVS Investor Care

Dividend Yield

4.45%

Dividend/Share (TTM)

2.48

Buy Backs (1Y)

2.08%

Diluted EPS (TTM)

5.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	360.9B	0	0	0
2023	330.9B	339.2B	347.8B	357.8B
2022	299.8B	307.9B	315.2B	322.5B
2021	271.0B	278.3B	285.1B	292.1B
2020	261.9B	263.8B	266.0B	268.7B
2019	210.5B	227.0B	244.3B	256.8B
2018	186.0B	187.2B	188.5B	194.6B
2017	178.8B	180.8B	182.4B	184.8B
2016	160.2B	166.7B	172.7B	177.5B
2015	143.0B	145.6B	149.2B	153.3B
2014	128.7B	132.1B	135.1B	139.4B
2013	123.1B	123.6B	125.3B	126.8B
2012	112.2B	116.5B	120.0B	123.1B
2011	97.9B	100.4B	103.4B	107.1B
2010	98.9B	97.9B	97.0B	95.8B
2009	89.5B	93.3B	97.0B	98.7B
2008	0	80.0B	83.8B	87.5B
2007	0	0	0	76.3B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of CVS Health Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	ludwig edward j	bought	53,879	53.879	1,000	-
May 02, 2024	mahoney michael f	bought	500,294	54.4923	9,181	-
Apr 01, 2024	lynch karen s	acquired	3,599,930	79.56	45,248	president and ceo
Apr 01, 2024	cowhey thomas f.	acquired	-	-	15,082	evp and cfo
Apr 01, 2024	joyner j. david	acquired	-	-	28,280	evp&president-pharmacyservices
Apr 01, 2024	lynch karen s	sold (taxes)	-4,928,980	79.56	-61,953	president and ceo
Apr 01, 2024	khichi samrat s.	acquired	-	-	12,569	evp, cpo and general counsel
Apr 01, 2024	cowhey thomas f.	sold (taxes)	-136,764	79.56	-1,719	evp and cfo
Apr 01, 2024	havanec laurie p.	sold (taxes)	-607,043	79.56	-7,630	evp and chief people officer
Apr 01, 2024	kane brian a	acquired	-	-	12,569	evp/president, aetna

Which funds bought or sold CVS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Sabal Trust CO	reduced	-18.67	-45,436	209,131	0.01%
May 06, 2024	Advisory Services Network, LLC	reduced	-3.8	-182,202	6,276,140	0.14%
May 06, 2024	Wealthspire Advisors, LLC	reduced	-11.62	-188,692	1,571,010	0.02%
May 06, 2024	Riverpoint Wealth Management Holdings, LLC	added	0.9	4,179	222,367	0.06%
May 06, 2024	Hemenway Trust Co LLC	reduced	-35.53	-3,130,850	5,845,590	0.51%
May 06, 2024	Manchester Capital Management LLC	added	131	241,105	421,213	0.05%
May 06, 2024	Valmark Advisers, Inc.	added	31.58	108,030	436,335	0.01%
May 06, 2024	Van Hulzen Asset Management, LLC	added	0.09	5,000	449,000	0.03%
May 06, 2024	Savant Capital, LLC	added	81.59	1,943,180	4,272,450	0.05%
May 06, 2024	Lesa Sroufe & Co	unchanged	-	3,000	329,000	0.31%

Are Funds Buying or Selling CVS?

Are funds buying CVS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CVS

No. of Funds

Unveiling CVS Health Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.14%	117,681,195	SC 13G/A
Jan 26, 2024	blackrock inc.	6.8%	87,020,610	SC 13G/A
Feb 09, 2023	vanguard group inc	8.94%	117,533,372	SC 13G/A
Feb 07, 2023	blackrock inc.	7.4%	96,668,258	SC 13G/A
Feb 09, 2022	vanguard group inc	8.28%	109,236,922	SC 13G/A
Feb 01, 2022	blackrock inc.	7.1%	93,556,500	SC 13G/A
Feb 10, 2021	vanguard group inc	8.05%	105,383,923	SC 13G/A
Jan 29, 2021	blackrock inc.	7.1%	92,478,369	SC 13G/A
Feb 12, 2020	vanguard group inc	8.05%	104,808,202	SC 13G/A
Feb 05, 2020	blackrock inc.	7.2%	94,158,010	SC 13G/A

Recent SEC filings of CVS Health Corp

View All Filings

Date Filed	Form Type	Document
May 07, 2024	424B3	Prospectus Filed
May 07, 2024	FWP	Prospectus Filed
May 03, 2024	13F-HR	Fund Holdings Report
May 02, 2024	4	Insider Trading
May 02, 2024	4	Insider Trading
May 01, 2024	10-Q	Quarterly Report
May 01, 2024	8-K	Current Report
Apr 16, 2024	PX14A6G	PX14A6G
Apr 05, 2024	DEF 14A	DEF 14A
Apr 05, 2024	DEFA14A	DEFA14A

Peers (Alternatives to CVS Health Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	462.0B	371.6B	9.96%	1.73%	20.64	1.24	14.64%	11.24%
CI	98.5B	206.0B	-4.33%	31.01%	25.56	0.48	12.55%	-43.95%
HCA	82.4B	66.7B	-4.37%	13.20%	15.06	1.23	9.59%	-4.59%
CVS	70.0B	360.9B	-25.27%	-20.02%	9.55	0.19	9.07%	78.49%
CNC	40.5B	155.5B	4.29%	11.16%	14.81	0.26	6.34%	84.42%
DVA	12.1B	12.3B	3.05%	54.33%	14.8	0.98	5.77%	58.74%
UHS	11.7B	14.3B	-2.27%	18.37%	16.37	0.82	6.59%	6.24%
MID-CAP
CHE	8.8B	2.3B	-7.98%	4.98%	30.96	3.83	5.96%	18.29%
ACHC	6.3B	3.0B	-11.24%	-2.13%	-553.66	2.09	10.92%	-104.06%
AMN	2.3B	3.8B	3.83%	-33.34%	10.82	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.08%	8.52%	34.65	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.7B	1.1B	2.42%	25.02%	26.07	1.57	11.45%	30.74%
BKD	1.4B	3.0B	8.71%	84.46%	-7.37	0.46	6.74%	20.73%
BEAT	54.0M	-	-2.35%	-2.35%	-3.69	-	-	-12.94%
AMS	19.6M	21.3M	10.24%	15.77%	36.7	0.92	8.00%	-62.25%

CVS Health Corp News

Latest updates

CVS Health Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-5.7%	88,437	93,813	89,764	88,921	85,278	83,846	81,159	80,636	76,826	76,604	73,794	72,616	69,097	69,554	67,056	65,341	66,755	66,889	64,810	63,431	61,646
Costs and Expenses	-4.7%	86,166	90,440	86,074	85,687	81,832	80,187	85,078	75,967	73,281	74,258	70,733	68,290	65,520	67,030	63,807	60,661	63,297	63,852	61,882	60,099	58,956
Operating Expenses	-	-	-	-	-	-	-	-	9,171	9,876	-	-	8,869	8,922	-	8,471	8,668	8,563	8,654	8,595	8,042	8,250
EBITDA Margin	-6.5%	0.05*	0.05*	0.05*	0.03*	0.04*	0.04*	0.03*	0.06*	0.06*	0.06*	0.06*	0.06*	-	-	-	-	-	-	-	-	-
Interest Expenses	3.8%	716	690	693	686	589	552	566	583	586	608	602	636	657	678	731	765	733	734	747	772	782
Income Taxes	-30.7%	456	658	754	656	737	818	-1,045	1,090	646	300	558	944	746	241	587	974	767	590	604	660	512
Earnings Before Taxes	-41.6%	1,580	2,705	3,019	2,570	2,879	3,150	-4,444	4,129	3,001	1,687	2,145	3,735	2,970	1,225	1,806	3,960	2,779	2,334	2,133	2,591	1,939
EBT Margin	-12.4%	0.03*	0.03*	0.03*	0.01*	0.02*	0.02*	0.01*	0.04*	0.04*	0.04*	0.04*	0.03*	-	-	-	-	-	-	-	-	-
Net Income	-45.3%	1,113	2,037	2,261	1,914	2,142	2,329	-3,406	3,039	2,355	1,393	1,598	2,791	2,224	965	1,224	2,986	2,012	1,747	1,530	1,936	1,421
Net Income Margin	-13.1%	0.02*	0.02*	0.02*	0.01*	0.01*	0.01*	0.01*	0.03*	0.03*	0.03*	0.03*	0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	218.4%	4,198	-3,547	2,171	5,317	6,454	-2,640	8,543	5,035	2,512	3,408	4,913	5,361	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.0%	249,743	249,728	251,306	250,071	239,330	228,275	231,212	230,279	232,873	233,052	234,891	231,164	229,606	230,715	232,898	235,495	230,639	222,449	220,113	218,904	219,768
Current Assets	-0.6%	67,473	67,858	70,143	67,756	68,706	65,633	68,341	62,142	61,483	60,035	60,842	56,559	55,719	56,369	59,211	62,506	58,958	50,302	48,185	46,901	47,857
Cash Equivalents	23.3%	10,107	8,196	13,043	13,807	14,618	12,945	17,563	12,463	11,611	9,408	9,826	7,119	5,598	11,043	9,532	15,145	10,337	8,408	5,469	6,338	6,168
Inventory	-9.3%	16,346	18,025	17,954	17,291	18,263	19,090	18,058	17,375	18,160	17,760	17,399	16,979	17,618	18,496	17,478	16,519	16,976	17,516	16,028	15,511	15,448
Net PPE	-	-	-	13,022	13,001	12,872	12,873	12,626	12,764	12,844	12,896	12,771	12,664	12,611	12,606	12,349	12,221	12,146	12,044	11,651	11,483	11,348
Goodwill	0%	91,272	91,272	91,261	91,260	5,909	78,150	78,086	78,560	79,060	79,121	79,121	79,552	79,552	79,552	79,579	80,057	79,993	79,749	79,548	79,485	79,075
Liabilities	1.4%	175,593	173,092	176,796	177,069	167,750	156,506	160,201	154,773	158,733	158,211	160,273	157,599	158,442	161,014	163,786	167,140	165,165	158,279	157,180	157,305	159,762
Current Liabilities	5.2%	83,319	79,189	81,553	79,206	75,054	69,421	72,409	68,457	69,780	67,719	64,709	59,311	60,104	62,017	62,044	63,694	59,560	53,303	52,544	49,376	50,631
Short Term Borrowings	1259.5%	2,719	200	-	1,000	-	-	-	-	-	-	-	-	252	-	-	-	255	-	1,070	446	3,005
Long Term Debt	-1.6%	57,694	58,638	59,782	61,419	56,450	50,476	50,848	50,797	52,063	51,971	56,832	59,294	59,270	59,207	61,552	63,481	65,735	64,699	64,206	66,941	67,888
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,192	5,828	3,781	3,778	3,894	3,893
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	63,481	65,735	64,699	64,206	66,941	67,888
Shareholder's Equity	-3.0%	74,150	76,461	74,337	73,002	71,580	71,469	71,487	75,736	74,034	74,841	74,618	73,565	71,164	69,701	69,112	68,355	65,474	64,170	62,933	61,599	60,006
Retained Earnings	0.4%	61,873	61,604	60,343	58,868	57,753	56,398	54,571	58,710	56,488	54,997	54,264	53,331	51,203	49,640	49,328	48,768	46,455	45,108	44,017	43,136	41,859
Shares Outstanding	-2.8%	1,252	1,288	1,287	1,282	1,279	1,300	1,313	1,313	1,312	1,319	1,318	1,316	-	-	-	-	-	-	-	-	-
Minority Interest	4.0%	182	175	173	276	198	300	328	322	310	306	310	321	314	312	305	333	334	306	319	317	320
Float	-	-	-	-	88,548	-	-	-	121,258	-	-	-	109,651	-	-	-	84,719	-	-	-	70,618	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	286.0%	4,903	-2,636	2,716	5,908	7,438	-1,952	9,123	5,443	3,563	4,005	5,521	5,847	2,892	3,567	1,874	7,119	3,305	2,634	2,928	5,338	1,948
Share Based Compensation	7.9%	137	127	154	204	103	106	105	147	89.00	138	114	145	87.00	112	109	83.00	96.00	98.00	129	112	114
Cashflow From Investing	-68.6%	-2,094	-1,242	-771	-10,362	-8,514	-119	-805	-2,130	-1,993	-1,440	-847	-1,107	-1,867	-1,234	-1,370	-1,333	-1,597	-709	-829	-910	-891
Cashflow From Financing	-26.2%	-1,227	-972	-2,697	3,626	2,726	-2,187	-3,218	-2,461	-2,650	-2,914	-1,930	-3,327	-3,185	-3,276	-6,117	-978	2,675	-1,244	-2,968	-4,258	816
Dividend Payments	7.8%	840	779	779	795	779	719	726	740	722	660	659	650	656	644	665	663	652	651	646	657	649
Buy Backs	302800.0%	3,027	-1.00	-3.00	-2.00	2,018	1,500	-	-	2,000	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CVS Income Statement

2024-03-31

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Premiums	$ 30,391	$ 24,352
Net investment income	454	334
Total revenues	88,437	85,278
Operating costs:
Cost of products sold	48,073	51,455
Health care costs	27,803	20,448
Loss on assets held for sale	0	349
Operating expenses	10,290	9,580
Total operating costs	86,166	81,832
Operating income	2,271	3,446
Interest expense	716	589
Other income	(25)	(22)
Income before income tax provision	1,580	2,879
Income tax provision	456	737
Net income	1,124	2,142
Net income attributable to noncontrolling interests	(11)	(6)
Net income attributable to CVS Health	$ 1,113	$ 2,136
Net income per share attributable to CVS Health:
Basic (in dollars per share)	$ 0.88	$ 1.66
Diluted (in dollars per share)	$ 0.88	$ 1.65
Weighted average shares outstanding:
Basic (in shares)	1,260	1,283
Diluted (in shares)	1,267	1,291
Dividends declared per share (in dollars per share)	$ 0.665	$ 0.605
Cost, Product and Service [Extensible List]	Products	Products
Products
Revenues:
Revenues	$ 53,724	$ 58,147
Services
Revenues:
Revenues	$ 3,868	$ 2,445

CVS Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Assets:
Cash and cash equivalents	$ 9,801	$ 8,196
Investments	3,288	3,259
Accounts receivable, net	32,217	35,227
Inventories	16,346	18,025
Other current assets	5,821	3,151
Total current assets	67,473	67,858
Long-term investments	24,074	23,019
Property and equipment, net	13,037	13,183
Operating lease right-of-use assets	17,045	17,252
Goodwill	91,272	91,272
Intangible assets, net	28,770	29,234
Separate accounts assets	3,271	3,250
Other assets	4,801	4,660
Total assets	249,743	249,728
Liabilities:
Accounts payable	13,717	14,897
Pharmacy claims and discounts payable	22,289	22,874
Health care costs payable	14,368	12,049
Policyholders’ funds	1,081	1,326
Accrued expenses	22,350	22,189
Other insurance liabilities	1,158	1,141
Current portion of operating lease liabilities	1,906	1,741
Short-term debt	2,719	200
Current portion of long-term debt	3,731	2,772
Total current liabilities	83,319	79,189
Long-term operating lease liabilities	15,742	16,034
Long-term debt	57,694	58,638
Deferred income taxes	4,184	4,311
Separate accounts liabilities	3,271	3,250
Other long-term insurance liabilities	5,178	5,459
Other long-term liabilities	6,205	6,211
Total liabilities	175,593	173,092
Shareholders’ equity:
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	0	0
Common stock, par value $0.01: 3,200 shares authorized; 1,771 shares issued and 1,252 shares outstanding at March 31, 2024 and 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and capital surplus	49,209	48,992
Treasury stock, at cost: 519 shares at March 31, 2024 and 480 shares at December 31, 2023	(36,773)	(33,838)
Retained earnings	61,873	61,604
Accumulated other comprehensive loss	(341)	(297)
Total CVS Health shareholders’ equity	73,968	76,461
Noncontrolling interests	182	175
Total shareholders’ equity	74,150	76,636
Total liabilities and shareholders’ equity	$ 249,743	$ 249,728

About CVS Health Corp

CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CEO	Ms. Karen Sue Lynch
WEBSITE	cvshealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	65535

CVS Health Corp Frequently Asked Questions

What is the ticker symbol for CVS Health Corp? What does CVS stand for in stocks?

CVS is the stock ticker symbol of CVS Health Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CVS Health Corp (CVS)?

As of Tue May 07 2024, market cap of CVS Health Corp is 69.96 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CVS stock?

You can check CVS's fair value in chart for subscribers.

What is the fair value of CVS stock?

You can check CVS's fair value in chart for subscribers. The fair value of CVS Health Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CVS Health Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CVS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CVS Health Corp a good stock to buy?

The fair value guage provides a quick view whether CVS is over valued or under valued. Whether CVS Health Corp is cheap or expensive depends on the assumptions which impact CVS Health Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CVS.

What is CVS Health Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, CVS's PE ratio (Price to Earnings) is 9.55 and Price to Sales (PS) ratio is 0.19. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CVS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CVS Health Corp's stock?

In the past 10 years, CVS Health Corp has provided -0.011 (multiply by 100 for percentage) rate of return.